National Center for Research Resources; Notice of Closed Meetings, 7280-7281 [05-2651]
Download as PDF
7280
Federal Register / Vol. 70, No. 28 / Friday, February 11, 2005 / Notices
Division Of Extramural Activities, National
Cancer Institute, National Institutes Of
Health, 6116 Executive Boulevard, Room
8057, MSC 8329, Bethesda, MD 20892–8329,
(301) 496–7421, kerwinm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2646 Filed 2–10–05; 8:45 am]
Contact Person: Harold L. Watson, PhD,
Scientific Review Administrator, Office of
Review, NCRR, National Institutes of Health,
6701 Democracy Boulevard, 1 Democracy
Plaza, Room 1070, MSC 4874, Bethesda, MD
20892–4874, (301) 435–0813,
watsonh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS)
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2647 Filed 2–10–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: March 16, 2005.
Time: 8 a.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel, Rockville; 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Harold L. Watson, PhD,
Scientific Review Administrator, Office of
Review, NCRR, National Institutes of Health,
6701 Democracy Blvd., Room 1078,
Bethesda, MD 20892, (301) 435–0813,
watsonh@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: April 4, 2005.
Time: 8 a.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: NCRR, OR, 6701 Democracy Blvd.,
Rockville, MD 20892 (Telephone Conference
Call).
VerDate jul<14>2003
17:18 Feb 10, 2005
Jkt 205001
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2650 Filed 2–10–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Contact Person: Harold L. Watson, PhD,
Scientific Review Administrator, Office of
Review, NCRR, National Institutes of Health,
6701 Democracy Boulevard, Room 1070,
MSC 4874, Bethesda, MD 20892–4874. (301)
435–0813. watsonh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS)
National Center for Research
Resources; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Initial Review Group,
Research Centers in Minority Institutions
Review Committee.
Date: March 15, 2005.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss program planning and
other matters.
Place: Double Tree Hotel, Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Closed: 9 a.m. to adjournment.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree Hotel, 1750 Rockville
Pike, Rockville, MD 20852.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
Scientific and Technical Review Board.
Date: March 24, 2005.
Time: 9 a.m. to adjournment.
Agenda: To review and evaluate grant
applications.
Place: Office of Review, Bethesda, MD
20892. (Telephone conference call.)
Contact Person: Sheryl K. Brining, PhD,
Director, Office of Review, NCRR, National
Institutes of Health, 6701 Democracy Blvd, 1
Democracy Plaza, Room 1074, MSC 4874,
Bethesda, MD 20892–4874. (301) 435–0809.
sb44k@nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: May 24–25, 2005.
Closed: May 24, 2005, 8 a.m. to
adjournment.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel, Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Carol Lambert, PhD,
Scientific Review Administrator, Office of
E:\FR\FM\11FEN1.SGM
11FEN1
Federal Register / Vol. 70, No. 28 / Friday, February 11, 2005 / Notices
Review, National Center for Research
Resources, National Institute of Health, 6701
Democracy Boulevard, 1 Democracy Plaza,
Room 1076, Bethesda, MD 20892–4874. (301)
435–0814. lambert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS.)
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2651 Filed 2–10–05; 8:45 am]
BILLING CODE 4140–01–M
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2652 Filed 2–10ndash;05; 8:45
am]
National Institutes of Health
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be opened to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: February 28, 2005.
Time: 10 a.m. to 12 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussions
concerning Institute programs and policies.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Closed: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
VerDate jul<14>2003
17:18 Feb 10, 2005
Jkt 205001
Closed: 7 p.m. to 9:30 p.m.
Agenda: Program Planning.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Lore Anne McNicol, PhD,
Director, Division of Extramural Research,
National Eye Institute, National Institutes of
Health, Bethesda, MD 20892.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
BILLING CODE 4140–01–M′
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Clinical Trials
Review Committee, February 28, 2005, 8
a.m. to March 2, 2005, 5 p.m., Sheraton
Inner Harbor Hotel, 300 South Charles
Street, Baltimore, MD 21201 which was
published in the Federal Register on
February 1, 2005, FR70:5191.
The meeting will start on February 27
at 6 p.m. and continue through March
1, 2005. The meeting is closed to the
public.
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2656 Filed 2–10–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
7281
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict.
Date: March 1–2, 2005.
Time: 3 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Rita Liu, PhD, Associate
Director, OEA, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1388.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict Meeting.
Date: March 9, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Mark Swieter, PhD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict Meeting.
Date: March 9, 2005.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Mark Swieter, PhD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
E:\FR\FM\11FEN1.SGM
11FEN1
Agencies
[Federal Register Volume 70, Number 28 (Friday, February 11, 2005)]
[Notices]
[Pages 7280-7281]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2651]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Research Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Research Resources
Special Emphasis Panel, Scientific and Technical Review Board.
Date: March 24, 2005.
Time: 9 a.m. to adjournment.
Agenda: To review and evaluate grant applications.
Place: Office of Review, Bethesda, MD 20892. (Telephone
conference call.)
Contact Person: Sheryl K. Brining, PhD, Director, Office of
Review, NCRR, National Institutes of Health, 6701 Democracy Blvd, 1
Democracy Plaza, Room 1074, MSC 4874, Bethesda, MD 20892-4874. (301)
435-0809. sb44k@nih.gov.
Name of Committee: National Center for Research Resources
Special Emphasis Panel.
Date: May 24-25, 2005.
Closed: May 24, 2005, 8 a.m. to adjournment.
Agenda: To review and evaluate grant applications.
Place: Double Tree Hotel, Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Carol Lambert, PhD, Scientific Review
Administrator, Office of
[[Page 7281]]
Review, National Center for Research Resources, National Institute
of Health, 6701 Democracy Boulevard, 1 Democracy Plaza, Room 1076,
Bethesda, MD 20892-4874. (301) 435-0814. lambert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure, 93.306, 93.333,
National Institutes of Health, HHS.)
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-2651 Filed 2-10-05; 8:45 am]
BILLING CODE 4140-01-M